Pacis, Scarlette
Bolzani, Anna
Heuck, Alexander
Gossens, Klaus
Kruse, Mathias
Fritz, Björn
Maywald, Ulf
Wilke, Thomas
Kunz, Christian
Funding for this research was provided by:
AbbVie Deutschland
Article History
Received: 29 September 2023
Accepted: 26 January 2024
First Online: 20 February 2024
Declarations
:
: Scarlette Pacis and Anna Bolzani are employees of Cytel. Alexander Heuck, Klaus Gossens, Mathias Kruse and Björn Fritz are AbbVie employees and may own AbbVie stock. Ulf Maywald has no potential conflict of interest, except those potentially related to his employer, AOK PLUS. Thomas Wilke is an employee of IPAM and he has received honoraria from several pharmaceutical/consultancy companies including Abbvie. Christian Kunz works at the Westpfalz-Klinikum GmbH, MVZ Kaiserslautern and declared no potential conflict of interest.
: Due to the non-interventional, retrospective nature of the analyzed data and because our analysis involved an anonymized dataset, neither ethical review nor informed consent of the patients was required according to German national legislation (§ 75 SGB X). As the responsible authority, the involved sickness fund (AOK PLUS) approved the use of the data for the purpose of this study.